Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Total Revenue	$ 1,127,046	$ 19,153,848	$ 7,213,253	$ 20,080,784
Operating Expenses
Cost of Sales	829,958	11,738,493	5,488,325	12,427,774
General and Administrative	2,798,137	2,305,859	6,048,990	4,633,244
Impairment of Note Receivable, Goodwill and Investment	308,423		751,922
Total Operating Expenses	3,936,518	14,044,352	12,289,237	17,061,018
(Loss) Income from Operations	(2,809,472)	5,109,496	(5,075,984)	3,019,766
Other Income (Expense)
Interest Expense	(94,091)		(113,214)
Foreign Exchange Transaction Gain	845,350	1,150,830	2,038,986	362,528
Realized Loss on Securities Investment	(192,205)	(10,557,229)	(344,673)	(10,688,542)
(Loss) Gain on Equity Method Investment	(856,724)	219,888	(1,978,142)	(48,388)
Loss on Consolidation of Alset Capital Acquisition Corp.		(21,657,036)		(21,657,036)
Other Expense	(36,999)		(38,570)
Other Income	139,201	987,531	209,354	1,090,538
Total Other Income (Expense), Net	1,659,507	(10,922,902)	(3,387,772)	(13,156,354)
Net Loss Before Income Taxes	(1,149,965)	(5,813,406)	(8,463,756)	(10,136,588)
Income Tax Expense
Net Loss	(1,149,965)	(5,813,406)	(8,463,756)	(10,136,588)
Net Income (Loss) Attributable to Non-Controlling Interest	89,149	(5,556)	(454,985)	(470,852)
Net Loss Attributable to Common Stockholders	(1,239,114)	(5,807,850)	(8,008,771)	(9,665,736)
Other Comprehensive Loss
Foreign Currency Translation Adjustment	(1,253,895)	(2,183,883)	(2,064,408)	(1,087,940)
Total Comprehensive Loss	(2,403,860)	(7,997,289)	(10,528,164)	(11,224,528)
Less Comprehensive Loss Attributable to Non-controlling Interests	(93,209)	(320,903)	(351,419)	(626,520)
Total Comprehensive Loss Attributable to Common Shareholders	$ (2,310,651)	$ (7,676,386)	$ (10,176,745)	$ (10,598,008)
Net Loss Per Share - Basic	$ (0.13)	$ (0.63)	$ (0.87)	$ (1.09)
Net Loss Per Share - Diluted	$ (0.13)	$ (0.63)	$ (0.87)	$ (1.09)
Weighted Average Common Shares Outstanding - Basic	9,235,119	9,235,119	9,235,119	8,845,250
Weighted Average Common Shares Outstanding - Diluted	9,235,119	9,235,119	9,235,119	8,845,250
Nonrelated Party [Member]
Other Income (Expense)
Interest Income	$ 122,415	$ 92,388	$ 343,155	$ 131,666
Unrealized Gain (Loss) on Securities Investment	247,319	9,027,846	423,953	6,543,729
Related Party [Member]
Other Income (Expense)
Interest Income	55,849		84,438
Unrealized Gain (Loss) on Securities Investment	1,429,392	9,812,880	(4,013,059)	11,109,151
Rental [Member]
Revenue
Total Revenue	705,011	690,967	1,425,505	1,324,778
Property [Member]
Revenue
Total Revenue		18,190,950	5,032,500	18,190,950
Biohealth [Member]
Revenue
Total Revenue				12,786
Other [Member]
Revenue
Total Revenue	$ 422,035	$ 271,931	$ 755,248	$ 552,270